Psychosomatic medicine and psychopharmacology, symbiosis of present and future

Psychosomatic medicine is a way of approaching problem and health, and psychosomatic disorders in general are pathological expression of biological, psychological and socioecological parameters of human health and illness. Psychopharmacology, on the other hand, is one of the youngest and rapidly developing disciplines of treating agents and has become a widely used tool on psychosomatic medicine. The antecedents of psychopharmacology are many, such as biochemical, physiological, biophysical, psychological and, of course, clinical. These antecedents combine and run through the psychiatry and psychosomatic medicine to bind them, just like the psychosomatic medicine has become the binding force of biopsychosocioecological antecedents. Psychopharmacological agents most used in psychosomatic medicine are antidepressants, anxiolytic agents, hypnotics, antipsychotics, beta-blockers and mood stabilizers. As psychopharmacology is moving rapidly from empirical to rational, it is reflecting the path of understanding the mechanism of many psychosomatic disorders and a symbiosis is taking place between these two for bringing successful control or for curing psychosomatic sufferings. The holistic management of psychosomatic medicine requires the need to bring back suffering patients free from disorder, but with multiple modalities, including psychopharmacology, to enhance the quality of life to what it was before the illness started. Non-specific, more curative these agents will be, the more control over the abnormal biopsychosocioecological process will occur in human sufferers and the symbiosis of present will bind more firmly to psychosomatic disorder in future.